Colchicine, fragmented QRS, coronavirus disease 2019, and more

Código QR

Colchicine, fragmented QRS, coronavirus disease 2019, and more

Guardado en:

Detalles Bibliográficos
Autor principal:	Çetin Erol
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/0ea3150a7b0e44128bc89197ae3a6a21
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study
por: İbrahim Halil Özdemir, et al.
Publicado: (2021)

Energy drinks, pulmonary hypertension, and many more
por: Çetin Erol
Publicado: (2021)

Does coexistence of fragmented QRS and cardiovascular disease have the ability to predict the mortality in hospitalized, critically ill patients with COVID-19?
por: Fahrettin Katkat, et al.
Publicado: (2021)

Coronavirus disease 2019 and flight safety
por: Sevgi Özcan
Publicado: (2021)

Coronavirus Disease 2019 and Cardiac Arrhythmias
por: Antoni Martínez-Rubio, et al.
Publicado: (2020)

Electrophysiology in the Era of Coronavirus Disease 2019
Publicado: (2020)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: Emilia D’Elia, et al.
Publicado: (2020)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

Treatment of Coronavirus Disease 2019: Shooting in the Dark
por: Juan Tamargo
Publicado: (2020)

Mechanisms of Myocardial Injury in Coronavirus Disease 2019
por: Aniket S Rali, et al.
Publicado: (2020)

Differential Diagnosis of Wide QRS Tachycardias
por: Demosthenes G Katritsis, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

Acute myocarditis after coronavirus disease 2019 vaccination
por: Beuy Joob, et al.
Publicado: (2021)

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
por: Mahmoud Abdelnabi, et al.
Publicado: (2020)

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
por: Rocco A Montone, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach
por: Estefania Oliveros, et al.
Publicado: (2020)

Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications
por: Chia Siang Kow, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Catheterisation Laboratory Considerations: “Looking for Essentials”
por: Syed Haseeb Raza Naqvi, et al.
Publicado: (2020)

Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation
por: Daniel X Augustine, et al.
Publicado: (2021)

The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine
por: Angela HEM Maas, et al.
Publicado: (2020)

Cardiopulmonary Ultrasonography for Severe Coronavirus Disease 2019 Patients in Prone Position
por: Aniket S Rali, et al.
Publicado: (2020)

Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
por: Dimitrios A. Vrachatis, et al.
Publicado: (2021)

Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis
por: Francesco Condello, et al.
Publicado: (2021)

Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era
por: Haytham Mously, et al.
Publicado: (2021)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
por: Ernest Spitzer, et al.
Publicado: (2020)

Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness
por: Maki Komiyama, et al.
Publicado: (2020)

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
por: Maki Komiyama, et al.
Publicado: (2020)

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
por: Maki Komiyama, et al.
Publicado: (2020)

Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis
por: Selçuk Şen, et al.
Publicado: (2021)

Cardiovascular Medical Education During the Coronavirus Disease 2019 Pandemic: Challenges, Adaptations, and Considerations for the Future
por: Hilary Shapiro, et al.
Publicado: (2021)

Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019
por: Burcu Uğurlu Ilgın, et al.
Publicado: (2021)

Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion
por: David Martínez-Sellés, et al.
Publicado: (2020)

Remote Clinics and Investigations in Arrhythmia Services: What Have We Learnt During Coronavirus Disease 2019?
por: Shohreh Honarbakhsh, et al.
Publicado: (2021)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Marco Rossato, et al.
Publicado: (2020)

Relationship between frontal QRS-T duration and the severity of coronary artery disease in who were non-diabetic and had stable angina pectoris
por: Halil Akın, et al.
Publicado: (2021)

Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research
por: Pier D Lambiase
Publicado: (2021)

GLP-1, SGLT-2, new devices for interventional cardiologists
por: Çetin Erol
Publicado: (2021)

Studies and Reviews on Central Sleep Apnea, Endovascular Therapy, Robotic Surgery, and the associated Clinical and Genetic Characteristics in Cardiology
por: Çetin Erol
Publicado: (2021)

Ramadan, TURKMI, REALITY HF, and so on…0
por: Çetin Erol
Publicado: (2021)

Carotid artery stenting, new devices and techniques for interventional cardiology and atrial fibrillation
por: Çetin Erol
Publicado: (2021)